跳至主要内容
临床试验/KCT0000549
KCT0000549已完成未知

Evaluation of clinical efficacy of autologous gamma-globulin therapy for the patients with recalcitrant atopic dermatitis

Ajou University Hospital0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

Tweenty adult patients with severe atopic dermatitis were treated by intramuscular injection of 50 mg autologous immunoglobulin (mainly IgG with a purity = 97%) twice a week for 4 weeks. Repeated intramuscular injections of autologous immunoglobulin significantly decreased the clinical severity and serum IgE concentration in patients with severe atopic dermatitis.

研究设计

研究类型
Interventional Study

入排标准

年龄范围
16(Year) 至 60(Year)(—)
性别
All

入选标准

  • Adult patients with recalcitrant atopic dermatitis (age = 16 years) whose clinical conditions has not been effectively controlled by current standard medical therapies (topical moisturizers, topical corticosteroids, topical calcineurin inhibitors, and oral antihistamines) for more than 2 months and who are also compatible with criteria for autologous blood donation will be recruited. Written informed consent on this study will be received from all the participating patients.
  • [Autologous blood donation criteria]
  • 1) Body weight: Men =50Kg, Women = 45Kg
  • 2) Blood Platelet: = 150,000/?
  • 3) Hemoglobin : = 11 g/dL
  • 4) Blood pressure: Systolic blood pressure 90 ~ 179 mmHg,
  • Diastolic blood pressure < 100mmHg
  • 5) Pulse : 50 ~ 100 (time/minute)
  • 6) Temperature : = 37.5?

排除标准

  • Exclusion criteria
  • 1) Patients under the age of 16 year.
  • 2) Patients who are unable to agree on their own (emergency patients, patients with mental disability, patients with limited capacity to consent due to stroke or delirium caused by diabetes).
  • 3) Patients with severe disease whose expected survival duration is less than 3 months.
  • 4) Pregnancy or planned pregnancy within 1 year
  • 5) Skin condition not appropriate for blood sampling and transfusion

研究者

发起方
Ajou University Hospital

相似试验